RNAseq Analysis of Microbial Gene Expression in Necrotizing Soft Tissue Infections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

35 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-12-31

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis: We hypothesize that RNAseq will allow us to learn more about the causative agents of necrotizing soft tissue infections (NSTI) and risk factors involved in acquiring these devastating infections

Tissue biopsies will be obtained from consented patients admitted with NSTI. Biopsies will be used for standard clinical analysis of bacterial species present or stored for later RNA sequencing. RNA sequencing will identify bacteria that are present within the infection site that may not be detected using standard culture techniques as well as reveal bacterial gene expression profiles within the NSTI site. Medical charts will also be reviewed for basic patient information as well as wound care management practices. We hope to identify bacterial species commonly present in these types of infections as well as risk factors predisposing individuals to NSTI's.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Severe Soft Tissue Infections: Perspectives of Patients and Significant Others

NCT02169128

Necrotizing Fasciitis

UNKNOWN

Study of the Human Skin Microbiome

NCT00764608

Healthy

WITHDRAWN

Application of NGS Technique in Precise Diagnosis of Infectious Diseases

NCT03232242

Next Generation Sequencing Infectious Disease

UNKNOWN

Tigecycline for Treatment of Rapidly Growing Mycobacteria

NCT00600600

Mycobacterium Abscessus Lung Disease Rapidly Growing Mycobacterial Lung Disease

COMPLETED PHASE2

Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections

NCT00428818

Infection

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Necrotizing Soft Tissue Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient or LAR agrees to the procedure and signs informed consent form
* Patient is at least 18 yrs of age
* Patient has been diagnosed with an NSTI